Srikanth Gajavelli
Impact in
-
- Chronic Myeloid Leukemia Treatments
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lung Cancer Treatments and Mutations 4
- Oncology 6
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 3
- Lung Cancer Research Studies 2
- Peptidase Inhibition and Analysis 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Harry Shamoon (2 shared papers)Jill P. Crandall (2 shared papers)Samir Parekh (1 shared paper)Yu‐Min Shen (1 shared paper)Farhad Ravandi (1 shared paper)Victor Gheţie (1 shared paper)Amit Verma (1 shared paper)Stefan K. Barta (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Annals of Oncology (3 papers)Diabetes (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)Oncotarget (1 paper)
- Partner nations
- United StatesSpainFrance
In The Last Decade
Srikanth Gajavelli
18 papers receiving 273 citations
Peers
Comparison fields: 5 of 48
- Hematology 42
- Genetics 35
- Oncology 65
- Biotechnology 21
- Endocrinology, Diabetes and Metabolism 35
Countries citing papers authored by Srikanth Gajavelli
This map shows the geographic impact of Srikanth Gajavelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srikanth Gajavelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srikanth Gajavelli more than expected).
Fields of papers citing papers by Srikanth Gajavelli
This network shows the impact of papers produced by Srikanth Gajavelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srikanth Gajavelli. The network helps show where Srikanth Gajavelli may publish in the future.
Co-authors
The 25 scholars most cited alongside Srikanth Gajavelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 69 | |
| 2 | 2006 | 39 | |
| 3 | 2018 | 36 | |
| 4 | 2011 | 33 | |
| 5 | 2009 | 30 | |
| 6 | 2023 | 16 | |
| 7 | 2024 | 15 | |
| 8 | 2019 | 11 | |
| 9 | 2016 | 8 | |
| 10 | 2013 | 6 | |
| 11 | 2016 | 6 | |
| 12 | 2023 | 2 | |
| 13 | 2020 | 2 | |
| 14 | 2025 | 2 | |
| 15 | 2015 | 2 | |
| 16 | 2012 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2019 | 1 |
About Srikanth Gajavelli
Srikanth Gajavelli is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Rheumatology and Cancer Research, having authored 18 papers that have together received 280 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Cancer Treatment and Pharmacology (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Genomics and Diagnostics (2 papers), Lung Cancer Research Studies (2 papers), Peptidase Inhibition and Analysis (2 papers), HER2/EGFR in Cancer Research (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). The work is most often cited by research in Hematology (42 citations), Genetics (35 citations), Oncology (65 citations), Biotechnology (21 citations) and Endocrinology, Diabetes and Metabolism (35 citations). Srikanth Gajavelli has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Harry Shamoon, Jill P. Crandall, Samir Parekh, Yu‐Min Shen, Farhad Ravandi, Victor Gheţie, Amit Verma, Stefan K. Barta, Ellen S. Vitetta and John Schindler. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Diabetes, The Journal of Clinical Endocrinology & Metabolism and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.